A. O'hea

发表

Linkage and mutational analysis of the CDAN1 gene reveals genetic heterogeneity in congenital dyserythropoietic anemia type I.

P. Vyas, D. Higgs, H. Tamary, 2006, Blood.

Clinical pilot study of a cytotoxic antiserum in myeloblastic leukemia

J. Schifferli, J. Wainscoat, M. Heyworth, 1982, American journal of hematology.

Circulating micromegakaryocytes in myelodysplasia.

W. Erber, D. Oscier, D. Mason, 1987, Journal of clinical pathology.

Acute transformation of essential thrombocythaemia: report of two cases.

W. Erber, N. O'connor, C. Bunch, 1986, Journal of clinical pathology.

MEGALOBLASTIC ANAEMIA IN A VEGETARIAN HINDU COMMUNITY

A. Price, I. Chanarin, M. Rinsler, 1985, The Lancet.

Ulceration associated with stable myelodysplastic syndrome: atypical pyoderma gangrenosum?

S. Burge, A. Harris, A. O'hea, 1998, Clinical and experimental dermatology.

A mystery unravels.

J. Thachil, A. O'hea, A. Watson, 2007, The American journal of medicine.

Mutational analysis of the CDAN1 gene in familial and sporadic congenital dyserythropoietic anaemia type 1

P. Vyas, H. Tamary, W. Wood, 2003 .

Congenital dyserythropoiesis characterized by marked macrocytosis, vitamin B12‐ and folate‐independent megaloblastic change and absence of the defining features of congenital dyserythropoietic anaemia types I or III

S. Wickramasinghe, A. O'hea, V. E. Andrews, 1996, British journal of haematology.